Flora Peyvandi / X
Jun 26, 2025, 12:53
Flora Peyvandi: Chinese Researchers Smoothly Enter the Gene‑Therapy Arena as the Fight for Hemophilia B Heats Up
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, posted on X:
”First Chinese HB gene therapy: ISTH2025”
They say it’s better to prevent than treat—so naturally, ISTH 2025 turned into a gene‑therapy playground for Hemophilia B.
The clinical gene sessions are serving up some seriously insightful management intel!
Stay updated on the latest breakthroughs in Hematology: Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch